Search
CEO of BGI Group Shares Cai Lei's Blood Sample: It Will Be Sequenced and Assembled into a 'Perfect' Genome
4 day ago /
Read about 0 minute
Author：小编
On December 23, 2025, Yin Ye, CEO of BGI Group, shared Cai Lei's blood sample on Weibo, stating that it would be sequenced and assembled into a 'perfect' genome to continue the joint fight against ALS. Cai Lei was diagnosed with ALS in 2019 and has devoted himself to drug development and the construction of a patient data platform over the years. In early 2023, Yin Ye and Cai Lei first collaborated, and in June of last year, they jointly established a research consortium laboratory.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
